Their findings revealed that silencing ARHGAP9 inhibited proliferation, migration, invasion and induced cell cycle G0/G1 arrest and apoptosis in breast cancer cells, effects that might be mediated by significant inhibition of ERK and p38 activity [34, 35]. Here, ARHGAP9 is linked to breast carcinoma.